GLP-1RA partially alleviates obesity-induced reproductive dysfunction driven by the interplay mechanisms of inflammation and metabolic dysregulation via the SIRT-associated pathway
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2025.178459 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Tashinga Walter Matiki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institute…. Hauptthemen laut MEDLINE: Obesity, Inflammation, Sirtuins, Reproduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Key Research and Development Program of China, CAMS.
Abstract (Originalsprache)
Obesity-induced reproductive dysfunction is driven by chronic low-grade inflammation and metabolic dysregulation. The potential modulatory effect of GLP-1RAs on the interplay mechanisms of inflammation and metabolic dysregulation in obesity-induced reproductive dysfunction remains unclear. Hence, we investigated the effect of semaglutide on reproductive function via the SIRT-associated pathway in obese female mice. Female mice were divided into three groups: control-normal diet (NC), obesity-high fat diet (HFD), and intervention-high fat diet + semaglutide (HS). Mice body weight, composition and metabolic response to glucose, insulin, and pyruvate were evaluated. Systemic and ovarian inflammatory cytokines (IL-1β, NF-κB, IL-6, TNF-α), reproductive hormones (P4, E2, FSH, LH), and ovarian expression of SIRT1, SIRT6, FOXO1, FOXO3a, NRF1, IRS1, iNOS, eNOS, p27 KIP1, and PTEN were evaluated. The ovarian tissues were analyzed for structural changes, lipid accumulation, oxidative stress, and follicular development. Oocyte's mitochondrial function, DNA damage, lipid and ROS levels, and fertility tests were assessed. Adiposity and metabolic dysregulation, mainly insulin resistance and IRS1 disruption, were observed in the obese group. The HFD group showed higher NF-κB-associated pro-inflammatory cytokine expressions, oxidative stress, FOXO1 and iNOS expression, reduced SIRT1, SIRT6, FOXO3a, NRF1, eNOS levels, and dysregulated p27 KIP1/PTEN colocalization. These observed changes were accompanied by reduced P4 and E2, elevated FSH and LH, disrupted ovarian morphology, ovarian and oocyte lipid accumulation, oocyte DNA damage, and reduced fertility outcomes in the HFD group. Semaglutide treatment alleviated the dysfunctions observed in the obese group. Our findings demonstrated that GLP-1RAs (semaglutide) have potential therapeutic effects on obesity-induced reproductive dysfunctions by modulating the interplay mechanisms of inflammation and metabolic dysregulation via the SIRT-associated pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
- Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China; Key Laboratory of Rep…
Förderung
- Fundamental Research Funds for the Central Universities
- National Key Research and Development Program of China
- CAMS
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
- Shanghai Clinical Research Center
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Shanghai Municipal Health Commission
Zitieren
APA
Matiki, T. W., Ul Haq Shah, M. Z., Yin, L., Liu, R., Zhu, K., Lin, Z., Sheng, J., & Hefeng, H. (2026). GLP-1RA partially alleviates obesity-induced reproductive dysfunction driven by the interplay mechanisms of inflammation and metabolic dysregulation via the SIRT-associated pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178459
Vancouver
Matiki TW, Ul Haq Shah MZ, Yin L, Liu R, Zhu K, Lin Z, et al. GLP-1RA partially alleviates obesity-induced reproductive dysfunction driven by the interplay mechanisms of inflammation and metabolic dysregulation via the SIRT-associated pathway. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178459
BibTeX
@article{Matiki2026,
author = {Matiki, Tashinga Walter and Ul Haq Shah, Mohd Zahoor and Yin, Lin and Liu, Rui and Zhu, Kejing and Lin, Zhongliang and Sheng, Jianzhong and Hefeng, Huang},
title = {GLP-1RA partially alleviates obesity-induced reproductive dysfunction driven by the interplay mechanisms of inflammation and metabolic dysregulation via the SIRT-associated pathway},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2025.178459}
}
EUVIMED